Rothschild & Co Redburn analyst Issie Kirby upgraded Sonova (SONVY) to Neutral from Sell with a price target of CHF 215, up from CHF 210. The firm says the weaker hearing aid market outlook and heightened competitive landscape are now priced into the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: